KRAS and neoplasm: In P6, the primary tumor was resected before the ctDNA test, and tissue KRAS mutation profiling was performed on the recurring/more advanced tumor of the primary site noted by image studies 7 months after the ctDNA test, returning a positive test result for KRAS p.G12V.